ReviewLaryngoscope investigative otolaryngology2026
Keratocystoma of the Parotid Gland: A Systematic Review of Clinicopathologic Characteristics.
Review in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Keratocystoma is a rare benign neoplasm of the parotid gland, histologically characterized by multicystic keratinizing stratified squamous epithelium. Due to its resemblance to squamous malignancies, it represents a diagnostic challenge. This systematic review aims to summarize all published cases of parotid gland keratocystoma and to integrate one newly identified case in order to define its clinicopathologic features and clinical outcomes. Methods: A systematic literature search of PubMed and Google Scholar was conducted without date restrictions in accordance with PRISMA 2020 guidelines. The protocol was registered in PROSPERO (CRD420251024191). Peer-reviewed case reports and case series of histopathologically confirmed keratocystoma limited to the parotid gland were included. Demographic, clinical, radiologic, histopathologic, immunohistochemical, therapeutic, and follow-up data were extracted and descriptively analyzed. Methodological quality was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklists. One additional institutional case treated at Hannover Medical School in March 2025 was included. Results: Fifteen patients (14 from the literature and one new case) were identified. The mean age was 36.9 years (range: 1-77 years) with a slight male predominance. All tumors presented as painless parotid swellings and were treated surgically, most commonly by partial or lateral parotidectomy. No recurrences were reported during a mean follow-up of 22.8 months. Histologically, all cases demonstrated consistent squamous epithelial features with immunohistochemical positivity for AE1/AE3, CK5/14, and p63. The newly reported case represents the oldest patient described to date. Conclusion: Keratocystoma of the parotid gland exhibits reproducible benign clinical behavior and characteristic histopathologic features. Surgical excision appears curative, supporting its classification as a distinct benign salivary gland neoplasm that should be considered in the differential diagnosis of cystic parotid lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.